Merck reports consistent growth and promising outlook in their Q1 2024 earnings call, driven by successful products KEYTRUDA and GARDASIL.
Merck Earnings Call - MRK
Merck reports consistent growth and promising outlook in their Q1 2024 earnings call, driven by successful products KEYTRUDA and GARDASIL.